#Drug Pricing

Explore our comprehensive coverage of drug pricing, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

1Articles

1Authors

16Total Views

CMS Announces Second Wave of Medicare Drug Price Negotiations Under Inflation Reduction Act, Targeting 15 High-Expenditure Therapeutics

Featured

By Mahnoor Zafar IqbalJun 19, 2026

CMS Announces Second Wave of Medicare Drug Price Negotiations Under Inflation Reduction Act, Targeting 15 High-Expenditure Therapeutics

CMS has selected 15 high-expenditure therapeutics for the second wave of Medicare drug price negotiations under the Inflation Reduction Act. The polic...

Read Full Story →

#Drug Pricing

CMS Announces Second Wave of Medicare Drug Price Negotiations Under Inflation Reduction Act, Targeting 15 High-Expenditure Therapeutics

Recent Articles